BMI, body mass index; AF, atrial fibrillation; NYHA, New York Heart Association; CHD, coronary heart disease; NT-ProBNP, N-terminal pro-B type natriuretic peptide; eGFR, estimated glomerular filtration rate; SUA, serum uric acid; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor antagonist; ARNI, angiotensin receptor neprilysin inhibitor; MRA, mineralocorticoid receptor antagonist; AADs, anti-arrhythmic drugs; TTE, transthoracic echocardiography; LAD, left atrial diameter; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction.

Table 2 Univariate and multivariate analyses for risk factors of the primary endpoint